Trial · NCT07888673
Transcraneal Magnetic Stimulation for Treatment of Non-nociceptive Pain in Chronic Diseases
NCT07888673, Not applicable, Completed, Hospital Donostia
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Transcraneal Magnetic Stimulation for Treatment of Non-nociceptive Pain in Chronic Diseases. Trials, record NCT07888673. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07888673
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Transcraneal Magnetic Stimulation for Treatment of Non-nociceptive Pain in Chronic Diseases
- NCT number
- NCT07888673
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 47 participants, actual
- Lead sponsor
- Hospital Donostia
- Conditions
- Stroke Sequelae, Chronic Pain, Fibromyalgia, Long COVID19
- Interventions
- Transcraneal Magnetic Stimulation (rTMS)
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of adverse effects | 1 year | Safety and adverse effects |
| Secondary | Visual Analogue Scale (VAS) | 1 year | Validated self-report measure consisting of a 10-cm line ranging from 0 ("no pain") to 10 ("worst imaginable pain"). Participants indicated their perceived pain intensity by marking a point along the scale, with higher scores reflecting greater pain severity. |
| Secondary | Fatigue Assessment Scale (FAS) | 1 year | A validated 10-item self-report questionnaire that measures both physical and mental fatigue. Each item is scored on a 5-point Likert scale, resulting in a total score ranging from 10 to 50, with higher scores indicating greater fatigue severity. |
| Secondary | Fibromyalgia Impact Questionnaire (FIQ) | 1 year | A validated disease-specific instrument that evaluates physical functioning, work-related difficulties, pain, fatigue, morning tiredness, stiffness, anxiety, and depression. Total scores range from 0 to 100, with higher scores indicating a greater impact of fibromyalgia and increased functional impairment. |
| Secondary | Fugl-Meyer Assessment (FMA) | 1 year | A validated stroke-specific scale that evaluates motor function, sensory function, balance, joint range of motion, and joint pain. Higher scores indicate better sensorimotor performance and lower levels of neurological impairment. |
| Secondary | Boston Diagnostic Aphasia Examination (BDAE) | 1 year | A standardized neuropsychological battery designed to evaluate aphasia severity and language performance across multiple domains, including spontaneous speech, auditory comprehension, repetition, reading, and writing. Higher scores indicate better language function and fewer aphasic impairments |
| Secondary | Communicative Effectiveness Index (CETI) | 1 year | A validated caregiver-rated measure of communication ability in everyday situations. The questionnaire evaluates the effectiveness of verbal communication across a variety of functional contexts, with higher scores indicating better communicative performance and greater independence in daily interactions. |
| Secondary | Epworth Sleepiness Scale (ESS) | 1 year | A validated 8-item self-report questionnaire that evaluates the likelihood of falling asleep in a variety of everyday situations. Total scores range from 0 to 24, with higher scores indicating greater levels of excessive daytime sleepiness. |
| Secondary | Short Form-36 Health Survey (SF-36) | 1 year | A validated 36-item questionnaire that evaluates eight domains of physical and mental health, including physical functioning, bodily pain, vitality, social functioning, and emotional well-being. Scores range from 0 to 100, with higher scores indicating better health-related quality of life. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07888673
GET https://conductscience.org/api/trials/v1/NCT07888673/registered